Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Baxter
Medtronic
AstraZeneca
Harvard Business School

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC. (D.N.J. 2014)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .

Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ZYDUS PHARMACEUTICALS USA INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-02-18 151 Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54…2014 18 October 2017 1:14-cv-03168 830 Patent None District Court, D. New Jersey External link to document
2015-10-13 169 7,053,092 (“the ’092 patent”), 8,017,615 (“the ’615 patent”), 8,580,796 (“the ’796 patent”), 8,…’600 patent”), 8,642,760 (“the ’760 patent”), and 8,759,350 (“the ’350 patent” or the “Patent”). The…drug claimed in a patent or the use of which is claimed in a patent” prior to the patent’s expiration. …various patents covering Otsuka’s brand name aripiprazole product, Abilify®. 1 1 The patents asserted…actions specifically include: U.S. Patent Nos. 5,006,528 (“the ’528 patent”), Case 1:14-cv-03168-JBS-KMW Document External link to document
2016-02-18 218 Entry of Summary Judgment Concerning U.S. Patent No. 8,759,350, Certification of Judgment Under Rule 54…2014 18 October 2017 1:14-cv-03168 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Harvard Business School
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.